Funder
Celgene Corp
University of Chicago
AstraZeneca PLC
The University of Chicago Medicine Comprehensive Cancer Center
Reference23 articles.
1. National Comprehensive Cancer Network. Thyroid Carcinoma (Version 3.2022). Available at https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed November 1, 2022.
2. Biologic and clinical perspectives on thyroid cancer;Fagin;N Engl J Med,2016
3. A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: a clinical outcomes and biomarker assessment;Cabanillas;Cancer,2015
4. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer;Schlumberger;N Engl J Med,2015
5. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial;Brose;Lancet,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献